array(3) { ["company_details"]=> array(13) { ["name"]=> string(29) "Becton, Dickinson and Company" ["slug"]=> string(37) "4601d-us-becton-dickinson-and-company" ["logo"]=> NULL ["description"]=> NULL ["address_street"]=> string(11) "1 Becton Dr" ["address_place"]=> string(14) "Franklin Lakes" ["address_region"]=> string(10) "New Jersey" ["founding_date"]=> string(10) "1897-02-28" ["website_domain"]=> string(6) "bd.com" ["website_url"]=> string(18) "https://www.bd.com" ["industry_codes"]=> array(2) { [0]=> string(46) "Surgical and Medical Instruments and Apparatus" [1]=> string(60) "Orthopedic, Prosthetic, and Surgical Appliances and Supplies" } ["employee_count"]=> int(1500) ["article_count"]=> int(414) } ["articles"]=> array(9) { [0]=> array(7) { ["title_en"]=> string(117) "148,933 Shares in Becton, Dickinson and Company (NYSE:BDX) Acquired by International Assets Investment Management LLC" ["snippet_en"]=> string(220) "International Assets Investment Management LLC bought a new position in Becton, Dickinson and Company (NYSE:BDX – Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the SEC." ["url"]=> string(157) "https://www.defenseworld.net/2024/04/09/148933-shares-in-becton-dickinson-and-company-nysebdx-acquired-by-international-assets-investment-management-llc.html" ["image_url"]=> string(78) "https://images.businessradar.com/articles/b5d345d4-cdc5-4e7e-9bc8-6388647b54f4" ["source"]=> string(16) "defenseworld.net" ["publication_date"]=> string(10) "2024-04-09" ["categories"]=> array(4) { [0]=> string(11) "Regulations" [1]=> string(18) "General Investment" [2]=> string(31) "Financial Update/Profit Warning" [3]=> string(11) "Acquisition" } } [1]=> array(7) { ["title_en"]=> string(91) "Becton, Dickinson and Company (NYSE:BDX) Shares Acquired by Pinnacle Financial Partners Inc" ["snippet_en"]=> string(300) "Pinnacle Financial Partners Inc lifted its holdings in shares of Becton, Dickinson and Company (NYSE:BDX – Free Report) by 13.5% during the 4th quarter, Holdings Channel.com reports. The firm owned 1,119 shares of the medical instruments supplier’ s stock after acquiring an additional 133 shares" ["url"]=> string(132) "https://www.defenseworld.net/2024/04/04/becton-dickinson-and-company-nysebdx-shares-acquired-by-pinnacle-financial-partners-inc.html" ["image_url"]=> string(78) "https://images.businessradar.com/articles/da9af854-c050-4a10-a2df-eebde66bf91e" ["source"]=> string(16) "defenseworld.net" ["publication_date"]=> string(10) "2024-04-04" ["categories"]=> array(5) { [0]=> string(16) "Share Repurchase" [1]=> string(31) "Financial Update/Profit Warning" [2]=> string(24) "Stock Research & Ratings" [3]=> string(12) "Stock Market" [4]=> string(11) "Acquisition" } } [2]=> array(7) { ["title_en"]=> string(99) "AngioDynamics Resolves Decade-Long Patent Litigation With Becton, Dickinson In Settlement Agreement" ["snippet_en"]=> string(300) "AngioDynamics, Inc. (NASDAQ:ANGO) signed a settlement agreement with Becton, Dickinson And Company (NYSE:BDX) to resolve all outstanding patent litigation with C.R. Bard. As per the settlement agreement, BD will provide AngioDynamics with a license for specific port patents, while AngioDynamics will" ["url"]=> string(135) "https://feedimo.com/story/129841413/angiodynamics-resolves-decade-long-patent-litigation-with-becton-dickinson-in-settlement-agreement/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/bb28b643-1545-49f0-832e-e0427cfd77c6" ["source"]=> string(11) "feedimo.com" ["publication_date"]=> string(10) "2024-04-03" ["categories"]=> array(4) { [0]=> string(15) "Deals & Tenders" [1]=> string(16) "Case Settlements" [2]=> string(5) "Legal" [3]=> string(13) "Collaboration" } } [3]=> array(7) { ["title_en"]=> string(87) "Filter Needles Market [Top Players ] Becton, Dickinson and Company(BD), Cardinal Health" ["snippet_en"]=> string(96) "Filter Needles Market [Top Players ] Becton, Dickinson and Company(BD), Cardinal Health - Amoré" ["url"]=> string(110) "http://amore.ng/worldwide/33/filter-needles-market-top-players-becton-dickinson-and-companybd-cardinal-health/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/21517188-5e9a-48ab-80af-c997ac44b76d" ["source"]=> string(8) "amore.ng" ["publication_date"]=> string(10) "2024-04-01" ["categories"]=> array(2) { [0]=> string(15) "Market Movement" [1]=> string(11) "Competition" } } [4]=> array(7) { ["title_en"]=> string(77) "Laboratory Diagnostics Equipment Market Business Insights, Key Trend Analysis" ["snippet_en"]=> string(135) "Laboratory Diagnostics Equipment Market Business Insights, Key Trend Analysis | Abbott, Danaher, Becton, Dickinson and Company - Amoré" ["url"]=> string(145) "http://amore.ng/news/47/laboratory-diagnostics-equipment-market-business-insights-key-trend-analysis-abbott-danaher-becton-dickinson-and-company/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/86dfa799-2fd6-477b-88ce-0b254c623675" ["source"]=> string(8) "amore.ng" ["publication_date"]=> string(10) "2024-04-01" ["categories"]=> array(0) { } } [5]=> array(7) { ["title_en"]=> string(83) "Becton, Dickinson and Company (NYSE:BDX) Shares Bought by Ameriprise Financial Inc." ["snippet_en"]=> string(300) "Ameriprise Financial Inc. boosted its position in shares of Becton, Dickinson and Company (NYSE:BDX - Free Report) by 9.2% in the third quarter, according to the company in its most recent filing with the SEC. The firm owned 3,630,351 shares of the medical instruments supplier's stock after acquiri" ["url"]=> string(73) "https://www.marketbeat.com/instant-alerts/nyse-bdx-sec-filing-2024-03-03/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/9236e194-c867-41ca-b986-6a1f0a0b9df6" ["source"]=> string(14) "marketbeat.com" ["publication_date"]=> string(10) "2024-03-03" ["categories"]=> array(5) { [0]=> string(31) "Financial Update/Profit Warning" [1]=> string(11) "Regulations" [2]=> string(18) "General Investment" [3]=> string(24) "Stock Research & Ratings" [4]=> string(12) "Stock Market" } } [6]=> array(7) { ["title_en"]=> string(122) "Cancer Biomarkers Market Size, Trends, Shares, Insights and Forecast – 2024-2031 | Abbott, Becton, Dickinson and Company" ["snippet_en"]=> string(152) "cancer biomarkers market is estimated to be valued at US$ 21,643.9 million in 2022 and is expected to exhibit a CAGR of 14.4% during the forecast period" ["url"]=> string(153) "https://www.einnews.com/pr_news/692543407/cancer-biomarkers-market-size-trends-shares-insights-and-forecast-2024-2031-abbott-becton-dickinson-and-company" ["image_url"]=> NULL ["source"]=> string(11) "einnews.com" ["publication_date"]=> string(10) "2024-03-01" ["categories"]=> array(4) { [0]=> string(12) "Stock Market" [1]=> string(15) "Market Movement" [2]=> string(9) "Valuation" [3]=> string(5) "R & D" } } [7]=> array(7) { ["title_en"]=> string(66) "BD and Camtech Health partner for at-home HPV testing in Singapore" ["snippet_en"]=> string(129) "Becton, Dickinson and Company (BD) has partnered with Camtech Health to enhance access to cervical cancer screening in Singapore." ["url"]=> string(68) "https://www.medicaldevice-network.com/news/bd-camtech-hpv-singapore/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/c747c1db-6ad2-4a15-9156-9fe38b4d4b20" ["source"]=> string(25) "medicaldevice-network.com" ["publication_date"]=> string(10) "2024-02-22" ["categories"]=> array(3) { [0]=> string(24) "Access and affordability" [1]=> string(24) "Employee Health & Safety" [2]=> string(16) "Customer Welfare" } } [8]=> array(7) { ["title_en"]=> string(79) "Assessing Onclarity HPV assay safety and efficacy for cervical cancer screening" ["snippet_en"]=> string(246) "A recent study evaluated the safety and effectiveness of the Onclarity HPV assay in detecting high-grade cervical disease, presenting findings on its comparability to predicate assays and potential for cost-saving benefits in screening practices." ["url"]=> string(118) "https://www.contemporaryobgyn.net/view/assessing-onclarity-hpv-assay-safety-and-efficacy-for-cervical-cancer-screening" ["image_url"]=> string(78) "https://images.businessradar.com/articles/4afbc494-a32d-4b16-bd21-7dfc47f4913b" ["source"]=> string(21) "contemporaryobgyn.net" ["publication_date"]=> string(10) "2024-02-21" ["categories"]=> array(3) { [0]=> string(26) "Product Quality and safety" [1]=> string(16) "Safety Disregard" [2]=> string(17) "Academic Research" } } } ["category_annotations"]=> array(30) { [0]=> array(2) { ["name"]=> string(12) "Stock Market" ["count"]=> int(43) } [1]=> array(2) { ["name"]=> string(24) "Quarterly/Annual Figures" ["count"]=> int(26) } [2]=> array(2) { ["name"]=> string(5) "Legal" ["count"]=> int(20) } [3]=> array(2) { ["name"]=> string(8) "Epidemic" ["count"]=> int(20) } [4]=> array(2) { ["name"]=> string(31) "Financial Update/Profit Warning" ["count"]=> int(19) } [5]=> array(2) { ["name"]=> string(11) "Acquisition" ["count"]=> int(18) } [6]=> array(2) { ["name"]=> string(15) "Market Movement" ["count"]=> int(17) } [7]=> array(2) { ["name"]=> string(13) "Collaboration" ["count"]=> int(15) } [8]=> array(2) { ["name"]=> string(18) "General Investment" ["count"]=> int(14) } [9]=> array(2) { ["name"]=> string(10) "Litigation" ["count"]=> int(14) } [10]=> array(2) { ["name"]=> string(5) "R & D" ["count"]=> int(13) } [11]=> array(2) { ["name"]=> string(11) "Regulations" ["count"]=> int(12) } [12]=> array(2) { ["name"]=> string(14) "Product Launch" ["count"]=> int(12) } [13]=> array(2) { ["name"]=> string(24) "Stock Research & Ratings" ["count"]=> int(10) } [14]=> array(2) { ["name"]=> string(46) "Management of Legal and Regulatory Environment" ["count"]=> int(9) } [15]=> array(2) { ["name"]=> string(12) "Board Change" ["count"]=> int(8) } [16]=> array(2) { ["name"]=> string(25) "Business Model Resilience" ["count"]=> int(8) } [17]=> array(2) { ["name"]=> string(18) "Expansion & Growth" ["count"]=> int(8) } [18]=> array(2) { ["name"]=> string(14) "Issuing Shares" ["count"]=> int(7) } [19]=> array(2) { ["name"]=> string(14) "Product Recall" ["count"]=> int(6) } [20]=> array(2) { ["name"]=> string(17) "Academic Research" ["count"]=> int(6) } [21]=> array(2) { ["name"]=> string(5) "Event" ["count"]=> int(5) } [22]=> array(2) { ["name"]=> string(25) "Leadership and Governance" ["count"]=> int(5) } [23]=> array(2) { ["name"]=> string(16) "Case Settlements" ["count"]=> int(5) } [24]=> array(2) { ["name"]=> string(21) "Cultural developments" ["count"]=> int(4) } [25]=> array(2) { ["name"]=> string(24) "Access and affordability" ["count"]=> int(4) } [26]=> array(2) { ["name"]=> string(5) "Award" ["count"]=> int(4) } [27]=> array(2) { ["name"]=> string(21) "Competitive Behaviour" ["count"]=> int(4) } [28]=> array(2) { ["name"]=> string(10) "Divestment" ["count"]=> int(4) } [29]=> array(2) { ["name"]=> string(19) "Green & Responsible" ["count"]=> int(4) } } } 4601d-us-becton-dickinson-and-company

Becton, Dickinson and Company

Location

New Jersey

Founded

1897-02-28

Website

https://www.bd.com

Articles

414 Articles

Category

Surgical and Medical Instruments and Apparatus

Orthopedic, Prosthetic, and Surgical Appliances and Supplies

Description

Articles

148,933 Shares in Becton, Dickinson and Company (NYSE:BDX) Acquired by International Assets Investment Management LLC

2024-04-09 (defenseworld.net)

148,933 Shares in Becton, Dickinson and Company (NYSE:BDX) Acquired by International Assets Investment Management LLC

International Assets Investment Management LLC bought a new position in Becton, Dickinson and Company (NYSE:BDX – Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the SEC.

Read more
Becton, Dickinson and Company (NYSE:BDX) Shares Acquired by Pinnacle Financial Partners Inc

2024-04-04 (defenseworld.net)

Becton, Dickinson and Company (NYSE:BDX) Shares Acquired by Pinnacle Financial Partners Inc

Pinnacle Financial Partners Inc lifted its holdings in shares of Becton, Dickinson and Company (NYSE:BDX – Free Report) by 13.5% during the 4th quarter, Holdings Channel.com reports. The firm owned 1,119 shares of the medical instruments supplier’ s stock after acquiring an additional 133 shares

Read more
AngioDynamics Resolves Decade-Long Patent Litigation With Becton, Dickinson In Settlement Agreement

2024-04-03 (feedimo.com)

AngioDynamics Resolves Decade-Long Patent Litigation With Becton, Dickinson In Settlement Agreement

AngioDynamics, Inc. (NASDAQ:ANGO) signed a settlement agreement with Becton, Dickinson And Company (NYSE:BDX) to resolve all outstanding patent litigation with C.R. Bard. As per the settlement agreement, BD will provide AngioDynamics with a license for specific port patents, while AngioDynamics will

Read more
Filter Needles Market [Top Players ] Becton, Dickinson and Company(BD), Cardinal Health

2024-04-01 (amore.ng)

Filter Needles Market [Top Players ] Becton, Dickinson and Company(BD), Cardinal Health

Filter Needles Market [Top Players ] Becton, Dickinson and Company(BD), Cardinal Health - Amoré

Read more
Laboratory Diagnostics Equipment Market Business Insights, Key Trend Analysis

2024-04-01 (amore.ng)

Laboratory Diagnostics Equipment Market Business Insights, Key Trend Analysis

Laboratory Diagnostics Equipment Market Business Insights, Key Trend Analysis | Abbott, Danaher, Becton, Dickinson and Company - Amoré

Read more
Becton, Dickinson and Company (NYSE:BDX) Shares Bought by Ameriprise Financial Inc.

2024-03-03 (marketbeat.com)

Becton, Dickinson and Company (NYSE:BDX) Shares Bought by Ameriprise Financial Inc.

Ameriprise Financial Inc. boosted its position in shares of Becton, Dickinson and Company (NYSE:BDX - Free Report) by 9.2% in the third quarter, according to the company in its most recent filing with the SEC. The firm owned 3,630,351 shares of the medical instruments supplier's stock after acquiri

Read more
Cancer Biomarkers Market Size, Trends, Shares, Insights and Forecast – 2024-2031 | Abbott, Becton, Dickinson and Company

2024-03-01 (einnews.com)

Cancer Biomarkers Market Size, Trends, Shares, Insights and Forecast – 2024-2031 | Abbott, Becton, Dickinson and Company

cancer biomarkers market is estimated to be valued at US$ 21,643.9 million in 2022 and is expected to exhibit a CAGR of 14.4% during the forecast period

Read more
BD and Camtech Health partner for at-home HPV testing in Singapore

2024-02-22 (medicaldevice-network.com)

BD and Camtech Health partner for at-home HPV testing in Singapore

Becton, Dickinson and Company (BD) has partnered with Camtech Health to enhance access to cervical cancer screening in Singapore.

Read more
Assessing Onclarity HPV assay safety and efficacy for cervical cancer screening

2024-02-21 (contemporaryobgyn.net)

Assessing Onclarity HPV assay safety and efficacy for cervical cancer screening

A recent study evaluated the safety and effectiveness of the Onclarity HPV assay in detecting high-grade cervical disease, presenting findings on its comparability to predicate assays and potential for cost-saving benefits in screening practices.

Read more

Newsletter subscription